Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
990.90Today’s High
1050.8052W low
542.4052W High
1094.00Open Price
995.20Prev. Close
927.0000Volume
650308.00Value
666110484.40Fundamentals
Market Cap Cr
20134.00
Price to Earnings
34.10
Price to Book Value
4.60
Dividend Yield
0.80
PE to Growth
0.20
Op Revenue TTM Cr
6118.10
Net Profit TTM Cr
590.21
Cash From Operating Activity Cr
723.95
Return on Equity %
7.82
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
03 May, 2024
31.8
Week
36.9
Month
48.8
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1022.00
PIVOT
First Resistance
1053.10
Second Resistance
1081.90
Third Resistance
1113.00
First Support
993.20
Second Support
962.10
Third Support
933.30
Relative Strength Index
61.38
Money Flow Index
79.59
MACD
5.35
MACD Signal
-0.55
Average True Range
33.8
Average Directional Index
17.94
Rate of Change (21)
1.52
Rate of Change (125)
43.65
Commodity Channel Index
114.4
Williams %R
-19.4
BETA
1 Month
1.25
3 Month
1.38
1 Year
0.55
3 Year
0.19
PRICE CHANGE ANALYSIS
↑ 3.44%
1 Week
Low
High
984.75
1050.8
↑ 1.98%
1 Month
Low
High
913.95
1050.8
↑ 6.99%
3 Months
Low
High
901.8
1094
↑ 40.81%
6 Months
Low
High
710.25
1094
↑ 82.73%
1 Year
Low
High
542.4
1094
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 1591.69 | 1487.80 | 1344.12 | 1309.08 | 1310.79 | 1354.89 | 1160.95 | 1315.91 | 1234.25 | 1191.48 | 1271.43 | |
| Operating Expenses Qtr | 1251.25 | 1271.38 | 1166.54 | 1137.94 | 1085.98 | 1109.13 | 1033.70 | 1013.01 | 950.08 | 952.82 | 992.72 | |
| Operating Profit Qtr | 337.14 | 207.46 | 165.73 | 169.18 | 224.23 | 245.29 | 126.63 | 291.30 | 282.75 | 236.95 | 276.97 | |
| EBIDT Qtr Cr | 340.44 | 216.41 | 177.57 | 171.14 | 224.81 | 245.76 | 127.25 | 302.90 | 284.16 | 238.66 | 278.71 | |
| Depreciation Qtr | 69.08 | 67.18 | 65.75 | 73.54 | 65.85 | 66.80 | 46.09 | 45.95 | 45.34 | 44.53 | 43.49 | |
| Net Profit Qtr | 233.24 | 133.84 | 97.53 | 130.54 | 119.13 | 146.44 | 72.46 | 251.37 | 193.58 | 156.35 | 192.69 | |
| Basic EPS Qtr | 11.87 | 6.81 | 4.96 | 6.64 | 6.06 | 7.45 | 3.69 | 12.79 | 9.85 | 7.95 | 9.80 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 5152.54 | 5086.55 | 5061.17 | 4267.30 | 3666.69 | |
| Operating Expenses Annual Cr | 4484.65 | 4126.61 | 3479.21 | 2929.65 | 2781.60 | |
| Operating Profit Annual | 664.35 | 908.80 | 1572.23 | 1202.90 | 878.67 | |
| Operating Profit Margin Annual % | 12.89 | 17.87 | 31.06 | 28.19 | 23.96 | |
| Total Expenses Annual Cr | 4806.60 | 4428.55 | 3644.58 | 3090.51 | 2902.06 | |
| EBIDT Annual Cr | 667.89 | 959.94 | 1581.96 | 1337.65 | 885.09 | |
| EBIDT Annual margin % | 12.96 | 18.87 | 31.26 | 31.35 | 24.14 | |
| Depreciation | 272.95 | 284.92 | 152.60 | 135.67 | 105.59 | |
| PAT Before ExtraOrdinary Items Annual Cr | 346.73 | 543.55 | 1175.39 | 969.40 | 611.21 | |
| Net Profit Annual | 346.73 | 543.55 | 1175.39 | 969.40 | 611.21 | |
| Basic EPS Annual | 17.64 | 27.65 | 60.67 | 51.42 | 32.42 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 4414.29 | 5290.34 | 5254.24 | 3346.02 | 2712.41 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 164.83 | 204.25 | 398.47 | 1079.26 | 595.90 | |
| Total Current Liabilities Annual Cr | 1551.30 | 1579.45 | 1123.47 | 1453.49 | 1240.72 | |
| Total Capital Plus Liabilities Annual Cr | 6130.42 | 7074.04 | 6776.18 | 5878.77 | 4549.03 | |
| Fixed Assets Annual | 2978.73 | 4075.33 | 3388.81 | 2846.44 | 2192.32 | |
| Total Non Current Assets Annual | 3350.20 | 4329.58 | 4402.23 | 3727.40 | 2713.02 | |
| Total Current Assets Annual | 2780.22 | 2744.46 | 2373.95 | 2151.37 | 1836.01 | |
| Total Assets Annual | 6130.42 | 7074.04 | 6776.18 | 5878.77 | 4549.03 | |
| Contingent Liabilities plus Commitments Annual Cr | 326.18 | 228.15 | 327.06 | 455.59 | 409.05 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 730.25 | 545.26 | 1485.30 | 539.75 | 808.80 | |
| Cash from Investing Activity Annual | -460.98 | -368.72 | -925.55 | -822.31 | -753.59 | |
| Cash from Financing Annual Activity | -261.16 | -216.64 | -533.60 | 166.13 | 79.67 | |
| Net Cash Flow Annual | 8.11 | -40.10 | 26.15 | -116.43 | 134.88 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 224.59 | 269.16 | 267.32 | 177.51 | 143.89 | |
| ROE Annual % | 7.85 | 10.27 | 22.37 | 28.97 | 22.53 | |
| ROCE Annual % | 8.62 | 12.28 | 25.28 | 27.16 | 23.56 | |
| Total Debt to Total Equity Annual | 0.14 | 0.12 | 0.04 | 0.50 | 0.32 | |
| EBDIT Annual Margin % | 12.97 | 19.06 | 31.31 | 32.36 | 24.18 |
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 1633.46 | 1605.09 | 1497.81 | 1407.34 | 1509.46 | 1475.34 | 1263.22 | 1426.01 | 1273.04 | 1294.52 | 1327.91 | |
| Operating Expenses Qtr | 1364.21 | 1386.69 | 1287.46 | 1194.23 | 1260.27 | 1242.27 | 1247.49 | 1255.63 | 1016.05 | 1035.09 | 1090.10 | |
| Operating Profit Qtr | 266.36 | 208.25 | 198.69 | 212.22 | 248.75 | 232.74 | 14.65 | 160.11 | 255.65 | 257.23 | 235.93 | |
| EBIDT Qtr Cr | 269.25 | 218.40 | 210.35 | 213.11 | 249.19 | 233.07 | 15.73 | 170.38 | 257.00 | 259.43 | 237.81 | |
| Depreciation Qtr | 69.45 | 67.56 | 66.18 | 74.12 | 66.51 | 67.70 | 67.10 | 123.08 | 55.94 | 54.60 | 53.15 | |
| Net Profit Qtr | 180.45 | 136.56 | 120.60 | 152.60 | 121.92 | 133.35 | -65.88 | 35.46 | 176.42 | 169.29 | 158.27 | |
| Basic EPS Qtr | 9.18 | 6.95 | 6.14 | 7.76 | 6.20 | 6.78 | -3.35 | 1.80 | 8.98 | 8.61 | 8.37 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 5655.36 | 5356.25 | 5403.15 | 4610.69 | 3944.06 | |
| Operating Expenses Annual Cr | 4944.24 | 4431.63 | 3835.58 | 3382.73 | 3061.10 | |
| Operating Profit Annual | 708.38 | 874.16 | 1557.55 | 1223.02 | 873.58 | |
| Operating Profit Margin Annual % | 12.53 | 16.32 | 28.83 | 26.53 | 22.15 | |
| Total Expenses Annual Cr | 5269.84 | 4736.14 | 4035.07 | 3567.21 | 3194.74 | |
| EBIDT Annual Cr | 711.12 | 924.62 | 1567.57 | 1227.96 | 882.96 | |
| EBIDT Annual margin % | 12.57 | 17.26 | 29.01 | 26.63 | 22.39 | |
| Depreciation | 275.43 | 286.78 | 183.47 | 157.32 | 115.23 | |
| PAT Before ExtraOrdinary Items Annual Cr | 372.91 | 515.65 | 1114.76 | 800.65 | 592.57 | |
| Net Profit Annual | 341.99 | 520.94 | 1178.11 | 828.82 | 584.37 | |
| Basic EPS Annual | 17.40 | 26.50 | 60.81 | 43.97 | 31.00 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 4370.47 | 5237.54 | 5127.61 | 3219.41 | 2718.83 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | -60.64 | -28.96 | -0.79 | |
| Total Non Current Liabilities Annual Cr | 175.43 | 167.96 | 361.16 | 1046.99 | 570.07 | |
| Total Current Liabilities Annual Cr | 1636.93 | 1716.53 | 1280.85 | 1751.60 | 1489.68 | |
| Total Capital Plus Liabilities Annual Cr | 6182.83 | 7122.03 | 6708.98 | 5989.04 | 4777.79 | |
| Fixed Assets Annual | 2999.73 | 4102.08 | 3970.96 | 3398.02 | 2706.07 | |
| Total Non Current Assets Annual | 3272.81 | 4261.24 | 4131.08 | 3526.30 | 2820.03 | |
| Total Current Assets Annual | 2910.02 | 2860.79 | 2577.90 | 2462.74 | 1957.76 | |
| Total Assets Annual | 6182.83 | 7122.03 | 6708.98 | 5989.04 | 4777.79 | |
| Contingent Liabilities plus Commitments Annual Cr | 317.96 | 228.15 | 349.23 | 386.98 | 260.88 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 723.95 | 552.36 | 1463.38 | 449.13 | 811.96 | |
| Cash from Investing Activity Annual | -447.59 | -371.97 | -838.81 | -731.63 | -755.60 | |
| Cash from Financing Annual Activity | -261.96 | -217.36 | -597.42 | 154.86 | 59.04 | |
| Net Cash Flow Annual | 14.40 | -36.97 | 27.15 | -127.64 | 115.40 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 222.36 | 266.47 | 257.80 | 169.25 | 144.19 | |
| ROE Annual % | 7.82 | 9.94 | 22.97 | 25.74 | 21.49 | |
| ROCE Annual % | 9.58 | 11.79 | 25.49 | 25.26 | 23.34 | |
| Total Debt to Total Equity Annual | 0.15 | 0.12 | 0.04 | 0.54 | 0.34 | |
| EBDIT Annual Margin % | 12.58 | 17.42 | 29.06 | 26.66 | 22.44 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Kotak Small Cap Fund | 1.76 | 74393548 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Chirayu Ramanbhai Amin | 2.13 | 74393510 | 0 | 0 |
| Malika Chirayu Amin | 1.53 | 74393511 | 0 | 0 |
| Pranav Chirayu Amin | 0.51 | 74393512 | 0 | 0 |
| Shaunak Chirayu Amin | 0.51 | 74393513 | 0 | 0 |
| Nirayu Limited | 35.63 | 74393521 | 0 | 0 |
| Alembic Limited | 28.54 | 74393522 | 0 | 0 |
| Udit Chirayu Amin | 0.51 | 74393543 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| DSP Midcap Fund | 3.92 | 74393547 |
| Kotak Small Cap Fund | 1.76 | 74393548 |
| Life Insurance Corporation Of India | 4.33 | 74393550 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Jul 28, 2023 | 8 | FINAL | Jul 28, 2023 | Equity Share |
| Aug 17, 2022 | 10 | INTERIM | Aug 18, 2022 | Equity Share |
| Jul 19, 2021 | 14 | FINAL | - | Equity Share |
| Mar 16, 2020 | 7 | INTERIM | Mar 17, 2020 | Equity Share |
| Mar 16, 2020 | 3 | SPECIAL | Mar 17, 2020 | Equity Share |
| Jul 18, 2019 | 5.5 | FINAL | - | Equity Share |
| Jul 18, 2018 | 4 | FINAL | - | Equity Share |
| Jul 11, 2017 | 4 | FINAL | - | Equity Share |
| Jul 20, 2016 | 4 | FINAL | - | Equity Share |
| Jul 22, 2015 | 3.5 | FINAL | - | Equity Share |
| Jul 17, 2014 | 3 | FINAL | - | Equity Share |
| Jul 29, 2013 | 2.5 | FINAL | - | Equity Share |
| Jul 31, 2012 | 1.4 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 09, 2024 | Audited Results & Final Dividend | - |
| Feb 05, 2024 | Quarterly Results | - |
| Nov 07, 2023 | Quarterly Results | - |
| Aug 04, 2023 | Quarterly Results | - |
| May 05, 2023 | Audited Results & Final Dividend | - |
| Feb 01, 2023 | Quarterly Results | - |
| Nov 11, 2022 | Quarterly Results | - |
| Aug 04, 2022 | Quarterly Results & Others | To change dividend type from Final Dividend to Interim Dividend |
| May 02, 2022 | Audited Results & Dividend | - |
| Feb 10, 2022 | Quarterly Results | - |
| Nov 10, 2021 | Quarterly Results | - |
| Jul 26, 2021 | Quarterly Results | - |
| May 04, 2021 | Audited Results & Dividend | - |
| Jan 19, 2021 | Quarterly Results | - |
| Oct 22, 2020 | Quarterly Results | - |
| Aug 06, 2020 | To consider raising of funds | - |
| Jul 27, 2020 | Others | Inter alia to consider fund raising by way of a qualified institutions placement. |
| Jul 22, 2020 | Quarterly Results | - |
| May 22, 2020 | Audited Results | - |
| Apr 23, 2020 | Quarterly Results | - |
| Mar 06, 2020 | Interim Dividend | - |
| Jan 22, 2020 | Quarterly Results | - |
| Oct 24, 2019 | Quarterly Results | - |
| Jul 29, 2019 | Quarterly Results | - |
| Jun 12, 2019 | Others | inter alia, to consider and approve the proposal for issue of NonConvertible Debentures on Private Placement Basis. |
| May 08, 2019 | Audited Results & Dividend | - |
| Jan 22, 2019 | Quarterly Results | - |
| Dec 14, 2018 | Others | To consider and approve the issue and allotment of Unsecured Redeemable Non-Convertible Debentures (NCDs) of upto Rs. 350 Crores on Private Placement Basis. |
| Dec 06, 2018 | Others | To consider and approve a fresh proposal for issue of Non-Convertible Debentures on Private Placement Basis, superceding the earlier resolution. |
| Oct 22, 2018 | Quarterly Results | - |
| Sep 10, 2018 | Others | To consider the proposal for issue of Non-Convertible Debentures on Private Placement Basis. |
| Jul 27, 2018 | Quarterly Results | - |
| May 16, 2018 | Audited Results & Dividend | - |
| Jan 31, 2018 | Quarterly Results | - |
| Nov 07, 2017 | Quarterly Results | - |
| Jul 20, 2017 | Quarterly Results | - |
| May 03, 2017 | Audited Results & Dividend | - |
| Jan 25, 2017 | Quarterly Results | - |
| Oct 25, 2016 | Quarterly Results | - |
| Jul 29, 2016 | Quarterly Results | - |
| Apr 27, 2016 | Audited Results & Dividend | - |
| Jan 21, 2016 | Quarterly Results | - |
| Oct 27, 2015 | Quarterly Results | - |
| Jul 31, 2015 | Quarterly Results | - |
| Apr 27, 2015 | Audited Results & Dividend | Appointed Mr. Pranav Amin as Joint Managing Director w.e.f. April 27, 2015. |
| Feb 04, 2015 | Quarterly Results | - |
| Oct 20, 2014 | Quarterly Results | - |
| Jul 28, 2014 | Quarterly Results | - |
| Apr 28, 2014 | Audited Results & Dividend | - |
| Jan 22, 2014 | Quarterly Results | - |
| Oct 25, 2013 | Quarterly Results | (Revised) |
| Aug 07, 2013 | Quarterly Results | - |
| May 02, 2013 | Audited Results & Dividend | - |
| Jan 21, 2013 | Quarterly Results | - |
| Oct 19, 2012 | Quarterly Results | - |
| Aug 09, 2012 | Quarterly Results | - |
| Apr 25, 2012 | Audited Results & Dividend | - |
| Feb 08, 2012 | Quarterly Results | - |
| Oct 19, 2011 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
03 May 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the intimation dated 3rd May, 2024 received from our RTA.
01 May 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith the Newspaper Publication related to transfer of Equity Shares of the Company to the Investor Education and Protection Fund published in Indian Express and Financial Express on 1st May, 2024.
30 Apr 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the intimation dated 30th April, 2024 received from our RTA.
30 Apr 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Under SEBI LODR Regulations, 2015
Please find attached herewith the Intimation of the Specimen Copy of the Notice sent to the Shareholders of the Company.
29 Apr 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30
Please find attached herewith the intimation Regulation 30 of SEBI LODR Regulations, 2015
26 Apr 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30
Please find attached herewith the Intimation under Regulation 30 of SEBI LODR, Regulations 2015.
25 Apr 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement Under Regulation 30 Of SEBI LODR
Kindly find attached herewith the Announcement under Regulation 30 of SEBI regulations, 2015.
25 Apr 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the Intimation dated 25th April, 2024 received from our RTA.
23 Apr 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith a copy of newspaper advertisement related to Notice of claiming shares from Company''s Unclaimed Suspense Account published in English language newspaper - Business Standard on 23rd April, 2024.
19 Apr 2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company ALEMBIC PHARMACEUTICALS LTD. 2 CIN NO. L24230GJ2010PLC061123 3 Report filed for FY 2023-2024 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2023-24, 2024-25 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) Not Applicable 8Quantum of (d), which has been met from (c)(e)* Not Applicable 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* Not Applicable Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2022-23, 2023-24 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Manisha SarafDesignation :-Company Secretary Name of the Chief Financial Officer :- Rajkumar Baheti Designation : -Director Finance and CFO Date: 19/04/2024
